Skip to content



Most accessed articles RSS

View all articles

Aims and scope

Tropical Diseases, Travel Medicine and Vaccines is an open access journal that considers basic, translational and applied research, as well as reviews and commentary, related to the prevention and management of healthcare and diseases in international travelers. Given the changes in demographic trends of travelers globally, as well as the epidemiological transitions which many countries are experiencing, the journal considers non-infectious problems including chronic disease among target populations of interest as well as infectious diseases.

Featured review: Preventing travel-related illness in elderly tourists

Lee et al. provide guidelines for pre-travel counseling, immunization, and pharmacology concerns unique to elderly patients seeking care in a travel clinic setting.


Editor in Chief - Dr Andrea Boggild

Dr Andrea Boggild is an Associate Professor in the Department of Medicine at the University of Toronto, and is also the Medical Director of the Tropical Disease Unit in the Division of Infectious Diseases at Toronto General Hospital.

In addition to these roles, she is the Parasitology Lead for the Public Health Ontario Laboratory and is a licensed Medical Microbiologist and Infectious Diseases physician, who provides care to patients with travel-acquired infectious diseases in her medical practice. 

As a Clinician Scientist in the Department of Medicine, she leads ongoing international research and clinical collaborations in the fields of leishmaniasis, malaria, and travel and migration health, and through this work has published over 100 peer-reviewed articles and several book chapters. 

She presently serves on the Editorial Board of Travel Medicine and Infectious Disease, as an Associate Editor for the Journal of Travel Medicine, and as the Tropical, Travel, and Emerging Infections Section co-editor for Current Infectious Disease Reports. She is a member of the Committee to Advise on Tropical Medicine and Travel (CATMAT), an external advisory body to the Public Health Agency of Canada, and is the Director of Epidemic Intelligence and Surveillance for CanTravNet, the Canadian consortium of GeoSentinel Surveillance Network sites.


2017 Journal Metrics

  • Speed
    108 days to first decision for reviewed manuscripts only
    99 days to first decision for all manuscripts
    158 days from submission to acceptance
    13 days from acceptance to publication

    99 Altmetric Mentions